You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 16, 2025

Suppliers and packagers for PENICILLIN-VK


✉ Email this page to a colleague

« Back to Dashboard


PENICILLIN-VK

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Teva PENICILLIN-VK penicillin v potassium FOR SOLUTION;ORAL 060456 ANDA Teva Pharmaceuticals USA, Inc. 0093-4125-73 100 mL in 1 BOTTLE (0093-4125-73) 1990-09-30
Teva PENICILLIN-VK penicillin v potassium FOR SOLUTION;ORAL 060456 ANDA Teva Pharmaceuticals USA, Inc. 0093-4125-74 200 mL in 1 BOTTLE (0093-4125-74) 1990-09-30
Teva PENICILLIN-VK penicillin v potassium FOR SOLUTION;ORAL 060456 ANDA Teva Pharmaceuticals USA, Inc. 0093-4127-73 100 mL in 1 BOTTLE (0093-4127-73) 1990-09-30
Teva PENICILLIN-VK penicillin v potassium FOR SOLUTION;ORAL 060456 ANDA Teva Pharmaceuticals USA, Inc. 0093-4127-74 200 mL in 1 BOTTLE (0093-4127-74) 1990-09-30
Teva PENICILLIN-VK penicillin v potassium FOR SOLUTION;ORAL 060456 ANDA A-S Medication Solutions 50090-0409-0 200 mL in 1 BOTTLE (50090-0409-0) 1990-09-30
Teva PENICILLIN-VK penicillin v potassium FOR SOLUTION;ORAL 060456 ANDA Proficient Rx LP 63187-533-00 100 mL in 1 BOTTLE (63187-533-00) 1990-09-30
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers for the Pharmaceutical Drug: Penicillin VK

Last updated: July 30, 2025

Introduction

Penicillin VK (phenoxymethylpenicillin) remains a cornerstone in antibiotic therapy, primarily used to treat bacterial infections such as pharyngitis, skin infections, and respiratory tract infections. Its continued demand sustains an extensive global supply chain comprising chemical manufacturers, formulators, and distributors. Understanding the landscape of suppliers is pivotal for pharmaceutical industry stakeholders seeking reliable sources of high-quality Penicillin VK.

Global Manufacturing Landscape

The production of Penicillin VK is predominantly concentrated among pharmaceutical chemical manufacturers in Europe, Asia, and North America. Major players often integrate from active pharmaceutical ingredient (API) synthesis—penicillin V—to finished drug formulation, ensuring quality control and regulatory compliance.

Leading Suppliers of Penicillin VK API

1. GlaxoSmithKline (GSK)

  • Overview: GSK historically has been a dominant supplier of penicillin antibiotics, including Penicillin VK. Their manufacturing facilities in the United Kingdom and Belgium produce high-grade APIs that meet stringent regulatory standards, such as EU GMP and FDA requirements.

  • Market Position: GSK's legacy in antibiotic production combined with continuous R&D investment sustains its role as a reliable supplier, especially for high-volume demand from global markets.

2. Teva Pharmaceutical Industries Ltd.

  • Overview: Based in Israel, Teva is among the largest generic pharmaceutical manufacturers globally, offering Penicillin VK API and finished formulations.

  • Quality Assurance: Teva maintains ISO-certified manufacturing plants adhering to GMP standards, ensuring product consistency and regulatory acceptance in multiple jurisdictions.

3. Sandoz (Novartis)

  • Overview: Sandoz, a division of Novartis, specializes in generics and biosimilars. Their manufacturing facilities in Europe produce Penicillin VK API compliant with international standards.

  • Supply Capabilities: Known for large-scale production and global distribution networks, Sandoz supplies pharmaceutical companies and wholesalers worldwide.

4. Zhejiang Huayi Pharmaceutical Co., Ltd.

  • Overview: A Chinese producer specializing in antibiotics and intermediates, including Penicillin VK API. Their facilities are audited for WHO-GMP standards, catering to both domestic and export markets.

  • Cost Competitiveness: Competitive pricing and volume-based supply possess the capacity to serve emerging markets.

5. Hubei ReAgent Biologicals Co., Ltd.

  • Overview: Based in China, Hubei ReAgent manufactures Penicillin VK API with certifications aligning with the US and European pharmacopoeias.

  • Market Reach: Their extensive distribution network extends across Asia, Africa, and Latin America, facilitating affordable access.

Finished Dosage Form Suppliers

For finished Penicillin VK tablets or capsules, several pharmaceutical companies serve as major formulators and distributors:

  • Pfizer Inc.
    Pfizer, historically associated with penicillin production, continues to supply Penicillin VK formulations globally, especially through licensed manufacturing partnerships.

  • Macleods Pharmaceuticals
    An Indian pharmaceutical company producing generic antibiotics, including Penicillin VK tablets for emerging markets.

  • Glenmark Pharmaceuticals
    Based in India, Glenmark offers Penicillin VK formulations with regulatory approvals across multiple continents.

Regulatory and Quality Standards

Global suppliers must adhere to regulatory frameworks such as:

  • U.S. Food and Drug Administration (FDA) regulations: For export to the United States.
  • European Medicines Agency (EMA): For the European market.
  • World Health Organization (WHO) GMP standards: Especially relevant for suppliers targeting developing regions.

Suppliers maintaining certifications such as ISO, CGMP, and WHO-GMP qualify for numerous markets and uphold product integrity.

Supply Chain Considerations and Risks

Supply reliability hinges on manufacturing capacity, geopolitical stability, raw material availability, and regulatory compliance. Recent global disruptions, including the COVID-19 pandemic, underscored vulnerabilities in antibiotic supply chains, prompting buyers to diversify suppliers and verify compliance rigorously.

Emerging Suppliers and Market Trends

The increasing demand for affordable antibiotics has led to the rise of Chinese and Indian manufacturers expanding capacities. Innovations include utilizing continuous manufacturing techniques to improve quality and reduce costs.

Additionally, biosynthesis approaches and synthetic biology hold promise for future penicillin production, potentially transforming supplier landscapes.

Conclusion

A robust supply of Penicillin VK requires strategic partnerships with reputable manufacturers adhering to global quality standards. Major pharmaceutical companies like GSK, Teva, and Sandoz dominate the API supply chain, complemented by regional producers in China and India. Ensuring supply security and regulatory compliance remains critical amid evolving market dynamics.


Key Takeaways

  • Major API Suppliers: GSK, Teva, Sandoz, Zhejiang Huayi, and Hubei ReAgent.
  • Finished Product Suppliers: Pfizer, Macleods Pharmaceuticals, Glenmark Pharmaceuticals.
  • Regulatory Compliance: Essential for global distribution; ISO, GMP, WHO-GMP certifications are key indicators of quality.
  • Market Trends: Increased regional manufacturing, biosynthesis, and supply diversification improve availability and reduce costs.
  • Supply Chain Risks: Geopolitical, logistical, and quality assurance factors must be diligently managed.

FAQs

1. What are the primary regions producing Penicillin VK API?
Main production regions include Europe (notably the UK and Belgium), China, and India. These regions host producers with established GMP-certified facilities aligned with international standards.

2. How do I verify the quality of Penicillin VK suppliers?
Ensure suppliers possess relevant certifications such as WHO-GMP, ISO, or US FDA approval. Audits and documentation of compliance, along with batch testing and quality assurance protocols, are vital.

3. Are generic Penicillin VK suppliers reliable?
Yes. Reputable generic manufacturers like Teva, Sandoz, and regional producers often meet strict regulatory standards, ensuring product quality comparable to branded counterparts.

4. What factors should influence supplier selection for Penicillin VK?
Factors include regulatory compliance, manufacturing capacity, supply stability, cost, geographic considerations, and adherence to quality management systems.

5. How has the COVID-19 pandemic impacted Penicillin VK supply chains?
The pandemic disrupted raw material supplies, logistics, and manufacturing operations, emphasizing the need for diversified sources and contingency planning in procurement strategies.


Sources
[1] World Health Organization. "WHO Lists of Validated Quality Control Laboratories." 2022.
[2] European Medicines Agency. "Good Manufacturing Practice." 2023.
[3] U.S. Food and Drug Administration. "Approved Drug Products with Therapeutic Equivalence Evaluations." 2023.
[4] Pharmaceutical Technology. "Global Antibiotic API Manufacturing Trends," 2022.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.